Cargando…

The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study

BACKGROUND: Aluminum phosphide (AlP) is a very effective indoor and outdoor pesticide. We investigated the effects of N-acetyl cysteine (NAC) on the survival time, hemodynamics, and cardiac biochemical parameters at various time intervals in some cases of AlP poisoning. METHODS: This research was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghaddosinejad, Fakhreddin, Farzaneh, Esmaeil, Ghazanfari-Nasrabad, Mahdi, Eizadi-Mood, Nastaran, Hajihosseini, Morteza, Mehrpour, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102994/
https://www.ncbi.nlm.nih.gov/pubmed/27917341
http://dx.doi.org/10.1186/s40064-016-3630-2
_version_ 1782466517034598400
author Taghaddosinejad, Fakhreddin
Farzaneh, Esmaeil
Ghazanfari-Nasrabad, Mahdi
Eizadi-Mood, Nastaran
Hajihosseini, Morteza
Mehrpour, Omid
author_facet Taghaddosinejad, Fakhreddin
Farzaneh, Esmaeil
Ghazanfari-Nasrabad, Mahdi
Eizadi-Mood, Nastaran
Hajihosseini, Morteza
Mehrpour, Omid
author_sort Taghaddosinejad, Fakhreddin
collection PubMed
description BACKGROUND: Aluminum phosphide (AlP) is a very effective indoor and outdoor pesticide. We investigated the effects of N-acetyl cysteine (NAC) on the survival time, hemodynamics, and cardiac biochemical parameters at various time intervals in some cases of AlP poisoning. METHODS: This research was a case–control study to evaluate 63 AlP poisoned patients during 2010–2012. Patients with cardiovascular complications of AlP to be treated with intravenous NAC plus conventional treatment were considered as the case group and compared with patients who did not receive NAC. NAC infusion was administered to the case group at 300 mg/kg for 20 h. The data gathered included age, sex, heart rate, Systolic blood pressure (SBP), creatine phosphokinase (CPK), creatine kinase MB (CK-MB), and ECG at the admission time and 12, 18, and 24 h after admission. Analysis of repeated measures was performed to check the variability of parameters over time. RESULTS: The mean ages in the case and control groups were 26.65 ± 1.06 (19–37 years) and 28.39 ± 1.11 (18–37 years), respectively (P = 0.266). Most of the patients were female (56.5%). CK-MB means were significantly different between the two groups, but no differences between the other variables were observed. Also, CK-MB, CPK, heart rate, and systolic blood pressure means became significantly different over time (0, 12, 18, and 24 h) in both groups (P < 0.001). NAC prevented sharp heart rate fluctuations in AlP patients in the case group. Regarding the outcomes, 17 patients died (10 patients in the control and 7 patients in the case groups). No side-effects of NAC were observed. CONCLUSION: Our patients could be managed by the positive role of NAC as the biochemical index of cardiotoxicity was found to elevate in both the case and control groups. Therefore, for the management protocol optimization, NAC evaluation should be done in further cases.
format Online
Article
Text
id pubmed-5102994
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-51029942016-12-02 The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study Taghaddosinejad, Fakhreddin Farzaneh, Esmaeil Ghazanfari-Nasrabad, Mahdi Eizadi-Mood, Nastaran Hajihosseini, Morteza Mehrpour, Omid Springerplus Research BACKGROUND: Aluminum phosphide (AlP) is a very effective indoor and outdoor pesticide. We investigated the effects of N-acetyl cysteine (NAC) on the survival time, hemodynamics, and cardiac biochemical parameters at various time intervals in some cases of AlP poisoning. METHODS: This research was a case–control study to evaluate 63 AlP poisoned patients during 2010–2012. Patients with cardiovascular complications of AlP to be treated with intravenous NAC plus conventional treatment were considered as the case group and compared with patients who did not receive NAC. NAC infusion was administered to the case group at 300 mg/kg for 20 h. The data gathered included age, sex, heart rate, Systolic blood pressure (SBP), creatine phosphokinase (CPK), creatine kinase MB (CK-MB), and ECG at the admission time and 12, 18, and 24 h after admission. Analysis of repeated measures was performed to check the variability of parameters over time. RESULTS: The mean ages in the case and control groups were 26.65 ± 1.06 (19–37 years) and 28.39 ± 1.11 (18–37 years), respectively (P = 0.266). Most of the patients were female (56.5%). CK-MB means were significantly different between the two groups, but no differences between the other variables were observed. Also, CK-MB, CPK, heart rate, and systolic blood pressure means became significantly different over time (0, 12, 18, and 24 h) in both groups (P < 0.001). NAC prevented sharp heart rate fluctuations in AlP patients in the case group. Regarding the outcomes, 17 patients died (10 patients in the control and 7 patients in the case groups). No side-effects of NAC were observed. CONCLUSION: Our patients could be managed by the positive role of NAC as the biochemical index of cardiotoxicity was found to elevate in both the case and control groups. Therefore, for the management protocol optimization, NAC evaluation should be done in further cases. Springer International Publishing 2016-11-10 /pmc/articles/PMC5102994/ /pubmed/27917341 http://dx.doi.org/10.1186/s40064-016-3630-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Taghaddosinejad, Fakhreddin
Farzaneh, Esmaeil
Ghazanfari-Nasrabad, Mahdi
Eizadi-Mood, Nastaran
Hajihosseini, Morteza
Mehrpour, Omid
The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title_full The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title_fullStr The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title_full_unstemmed The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title_short The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
title_sort effect of n-acetyl cysteine (nac) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102994/
https://www.ncbi.nlm.nih.gov/pubmed/27917341
http://dx.doi.org/10.1186/s40064-016-3630-2
work_keys_str_mv AT taghaddosinejadfakhreddin theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT farzanehesmaeil theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT ghazanfarinasrabadmahdi theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT eizadimoodnastaran theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT hajihosseinimorteza theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT mehrpouromid theeffectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT taghaddosinejadfakhreddin effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT farzanehesmaeil effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT ghazanfarinasrabadmahdi effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT eizadimoodnastaran effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT hajihosseinimorteza effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy
AT mehrpouromid effectofnacetylcysteinenaconaluminumphosphidepoisoninginducingcardiovasculartoxicityacasecontrolstudy